[go: up one dir, main page]

WO2005035528A3 - Triazole derivatives as antibacterial agents - Google Patents

Triazole derivatives as antibacterial agents Download PDF

Info

Publication number
WO2005035528A3
WO2005035528A3 PCT/IB2004/003360 IB2004003360W WO2005035528A3 WO 2005035528 A3 WO2005035528 A3 WO 2005035528A3 IB 2004003360 W IB2004003360 W IB 2004003360W WO 2005035528 A3 WO2005035528 A3 WO 2005035528A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibacterial agents
triazole derivatives
formula
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2004/003360
Other languages
French (fr)
Other versions
WO2005035528A2 (en
Inventor
Selvakumar Natesan
Jagattaran Das
Mohamed Takhi
Sanjay Trehan
Javed Iqbal
Sitaram Kumar Magadi
Sreenivas Kandepu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of WO2005035528A2 publication Critical patent/WO2005035528A2/en
Publication of WO2005035528A3 publication Critical patent/WO2005035528A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel triazole compounds of formula (I), their prodrugs, their pharmaceutically acceptable salts and their stereoisomers thereof. The present invention also relates to a process for the preparation of the novel compound of the formula (I).
PCT/IB2004/003360 2003-10-14 2004-10-14 Triazole derivatives as antibacterial agents Ceased WO2005035528A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN824CH2003 2003-10-14
IN824/CHE/2003 2003-10-14

Publications (2)

Publication Number Publication Date
WO2005035528A2 WO2005035528A2 (en) 2005-04-21
WO2005035528A3 true WO2005035528A3 (en) 2005-06-02

Family

ID=34430677

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/003360 Ceased WO2005035528A2 (en) 2003-10-14 2004-10-14 Triazole derivatives as antibacterial agents

Country Status (1)

Country Link
WO (1) WO2005035528A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696352B2 (en) 2004-06-18 2010-04-13 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
JP5020073B2 (en) 2004-06-18 2012-09-05 ミレニアム ファーマシューティカルズ インク． Factor Xa inhibitor
US20070060658A1 (en) * 2005-08-31 2007-03-15 Diaz David D Stabilization of organogels and hydrogels by azide-alkyne [3+2] cycloaddition
BRPI0711296A2 (en) 2006-05-05 2011-08-23 Millennium Phamaceutical Inc xa factor inhibitors
WO2011051960A2 (en) * 2009-09-25 2011-05-05 Cadila Healthcare Limited Process for the preparation of rapamycin derivatives
EP2513094B1 (en) 2009-12-17 2015-12-16 Millennium Pharmaceuticals, Inc. Crystalline salts of a factor xa inhibitor
US8742120B2 (en) 2009-12-17 2014-06-03 Millennium Pharmaceuticals, Inc. Methods of preparing factor xa inhibitors and salts thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051819A2 (en) * 2000-12-26 2002-07-04 Dr. Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
WO2003059894A1 (en) * 2002-01-18 2003-07-24 Dr.Reddy's Laboratories Ltd. Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051819A2 (en) * 2000-12-26 2002-07-04 Dr. Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
WO2003059894A1 (en) * 2002-01-18 2003-07-24 Dr.Reddy's Laboratories Ltd. Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.

Also Published As

Publication number Publication date
WO2005035528A2 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
WO2005082892A3 (en) Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
WO2004062601A3 (en) Antibacterial agents
WO2002024632A3 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
WO2005046589A3 (en) Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
CA2445306A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
TW200728307A (en) Novel spirochromanone derivatives
MXPA02003977A (en) INHIBITORS OF agr;L.
WO2006053255A3 (en) Novel betulin derivatives, preparation thereof and use thereof
WO2007009656A3 (en) Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
BR0108893B1 (en) pharmaceutical composition containing azetidine derivatives, azetidine derivative compound, and process for the preparation of compounds.
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2008142720A3 (en) Quinazolin-oxime derivatives as hsp90 inhibitors
WO2003082205A3 (en) Compounds and methods
WO2007109578A3 (en) Substituted gamma lactams as prostaglandin ep2 agonists
WO2007072158A3 (en) Pyrimidine derivatives for the treatment of abnormal cell growth
WO2004091504A3 (en) Substituted quinobenzoxazine analogs
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
WO2004096823A3 (en) Novel ketolide derivatives
WO2001053257A3 (en) Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them
CA2469592A1 (en) Hiv integrase inhibitors
NO20052074L (en) Substituted benzoxazinones and uses thereof.
WO2005003087A3 (en) Oxazole derivatives as antibacterial agents
WO2003082192A3 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2004111008A3 (en) Use of a compound of formula i for making a pharmaceutical composition
WO2007017728A3 (en) Novel heterocyclic compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase